News from the Esprinet world

POTENTIAL PUBLIC TENDER OFFER ON CELLULARLINE SHARES, APPROVAL TO CARRY OUT A LIMITED DUE DILIGENCE

ESPRINET CLOSES THE FIRST QUARTER OF 2022 ABOVE EXPECTATIONS DESPITE A MORE UNCERTAIN CONTEXT AND THE COMPARISON WITH AN EXTREMELY POSITIVE FIRST QUARTER OF 2021 THE 2022 GUIDANCE FORECASTS ADJ. EBITDA UP BY +8%

Esprinet submits to the Board of Directors of Cellularline a non-binding letter of intent aimed at launching a public tender offer